Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) is applied in patients with advanced neuroendocrine tumors. Co-infused amino acids (AA) should prevent nephrotoxicity. The aims of this study were to correlate the incidence of AA-induced hyperkalemia (HK) (≥5.0 mmol/l) and to identify predict...

詳細記述

保存先:
書誌詳細
出版年:EJNMMI Res
主要な著者: Lapa, Constantin, Werner, Rudolf A, Bluemel, Christina, Lueckerath, Katharina, Muegge, Dirk O, Strate, Alexander, Haenscheid, Heribert, Schirbel, Andreas, Allen-Auerbach, Martin S, Bundschuh, Ralph A, Buck, Andreas K, Herrmann, Ken
フォーマット: Artigo
言語:Inglês
出版事項: Springer 2014
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4412196/
https://ncbi.nlm.nih.gov/pubmed/25977880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0074-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料